Drug Interactions in Chemotherapy

  • S. E. Smith
Part of the Chemotherapy book series (CT, volume 4)


There are few topics more calculated to cause anxiety among doctors than that of drug interaction. Yet, considering the frequency of multiple drug prescription and even multiple drug consumption, true drug interactions are remarkably uncommon and interactions of serious consequence rare. A study of such events does, however, assist our understanding of the principles of drug action in man and may the re fore, help us to use our therapeutic armamentarium more wisely and more effectively. A theoretical approach to the problems involved is therefore justified.


Drug Interaction Tubular Cell Enzyme Induction Fusidic Acid Sodium Salicylate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kunin, C.M. and Finland, M. (1961). Clinical pharmacology of the tetracycline antibiotics. Clin. Pharmac. Ther. 2, 51–69.Google Scholar
  2. 2.
    Barr, W.H., Adir, J. and Garrettson, L. (1971). Decrease of tetracycline absorption in man by sodium bicarbonate. Clin Pharmac. Ther. 12, 779–784.Google Scholar
  3. 3.
    Neuvonen, P.J. and Turakka, H. (1974). Inhibitory effect of various iron salts on the absorption of tetracycline in man. Eur. J. clin. Pharmac. 7, 357–360.CrossRefGoogle Scholar
  4. 4.
    Boman, G. (1974). Serum concentration and half-life of ri-fampicin after simultaneous oral administration of acid or isoniazid. Eur. J. clin. Pharmac. 7, 217–225.CrossRefGoogle Scholar
  5. 5.
    Boman, G., Lundgren, P. and Stjernstrom, G. (1975). Mechanism of the inhibitory effect of PAS granules on the absorption of rifampicin: adsorption of rifampicin by an excipient, bentonite. Eur. J. clin. Pharmac. 8. 293–299.CrossRefGoogle Scholar
  6. 6.
    Silverman, W.A., Anderson, D.H., Blanc, W.A. and Crozier, N. (1956). A difference in mortality rate and incidence of kernicterus among premature infants alloted to two pr -phylactic antibacterial regimens. Pediatrics, Springs-field 18, 614–625.Google Scholar
  7. 7.
    Rolinson, G.N. and Sutherland, R. (1965). The binding of antibiotics to serum proteins. Brit. J. Pharmacol. 25, 638–650.PubMedGoogle Scholar
  8. 8.
    Smith, S.E. and Rawlins, M.D. (1973). Variability in human drug response. Butterworths, London. (Appendix C).Google Scholar
  9. 9.
    Christensen, L.K., Hansen, J.M. and Kristensen, M. (1963). Sulphaphenazole — induced hypoglycaemic attacks in tol-butamide-treated diabetics. Lancet, 2, 1298–1301.PubMedCrossRefGoogle Scholar
  10. 10.
    Conney, A.H. (1967). Pharmacological implications of micro somal enzyme induction. Pharmacol. Rev. 19, 317–366.PubMedGoogle Scholar
  11. 11.
    Busfield D., Child, K.J., Atkinson, R.M. and Toinich, E.G. (1963). An effect of phenobarbitone on blood-leveis of griseofulvin in man. Lancet, 2, 1042–1013.PubMedCrossRefGoogle Scholar
  12. 12.
    Catalano, P.M. and Cullen, S.I. (1966). Warfarin antagonism by griseofulvin. Clin. Res. 14, 266.Google Scholar
  13. 13.
    Neuvonen, P.J. and Pentilla, O. (1974). Interaction between doxycycline and barbiturates. Brit. med. J., 1, 535–536.PubMedCrossRefGoogle Scholar
  14. 11.
    Bolt, H.M., Kappus, H. and Bolt, M. (1975). Effect of ri-fampicin treatment on the metabolism of oestradiol and 17–03b1-ethinyloestradiol by human liver microsomes. Eur. J. clin. Pharmac. 8, 301–307.CrossRefGoogle Scholar
  15. 15.
    Paber, O.K., Mouridsen, H.T. and Skovsted, L. (1975). The effect of chloramphenicol and sulphaphenazole on the biotransformation of cyclophosphamide in man. Brit. J. clin. Pharmac. 2, 281–285.Google Scholar
  16. 16.
    Hansen, J.M., Siersback-Nielsen, K., Skovsted, L., Kampmann, J.P. and Lumholtz, B. (1975). Potentiation of warfarin by co-trimoxazole. Brit. med. J. 2, 684.Google Scholar
  17. 17.
    Brennan, R.W., Dehejia, H., Kutt, H. and McDowell, P. (1968). Diphenylhydantoin intoxication attendant to slow inacti-vation of isoniazid. Neurology, Minneap. 18, 282Google Scholar
  18. 18.
    Hanngren, A., Borgå, O. and Sjoqvist, P. (1970). Inactiva-tion of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS). Scand. J. resp. Bis. 51, 61–69.Google Scholar
  19. 19.
    Burnell, J.M. and Kirby, W.M.M. (1951). Effectiveness of a new compound, benemid, in elevating serum penicillin concentrations. J. clin. Invest. 30, 697–700.PubMedCrossRefGoogle Scholar
  20. 20.
    Tune, B.M. (1972). Effect of organic acid transport inhibitors on renal cortical uptake and proximal tubular toxicity of cephaloridine. J. Pharmac. exp. Ther, 181. 250–256.Google Scholar
  21. 21.
    Dodds, M.G. and Poord, R.D. (1970). Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine. Brit. J. Pharmac. 40, 227–236.Google Scholar
  22. 22.
    Poord, R.B. (1975). Cephaloridine, cephalothin and the kidney. J. antimicrob. Chemother. 1 (3). In press.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • S. E. Smith
    • 1
  1. 1.Department of Pharmacology, Medical SchoolSt. Thomas’s HospitalLondon S.E.1UK

Personalised recommendations